Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and phosphoramidon

arg-3-hyp-7-phe-bradykinin has been researched along with phosphoramidon in 1 studies

Compound Research Comparison

Studies
(arg-3-hyp-7-phe-bradykinin)
Trials
(arg-3-hyp-7-phe-bradykinin)
Recent Studies (post-2010)
(arg-3-hyp-7-phe-bradykinin)
Studies
(phosphoramidon)
Trials
(phosphoramidon)
Recent Studies (post-2010) (phosphoramidon)
52237811233

Protein Interaction Comparison

ProteinTaxonomyarg-3-hyp-7-phe-bradykinin (IC50)phosphoramidon (IC50)
ThermolysinBacillus thermoproteolyticus0.033
NeprilysinRattus norvegicus (Norway rat)0.0578
NeprilysinOryctolagus cuniculus (rabbit)0.0028
NeprilysinHomo sapiens (human)0.0405
Angiotensin-converting enzyme Homo sapiens (human)0.615
Endothelin-converting enzyme 1Homo sapiens (human)1.0695
P2Y purinoceptor 12Homo sapiens (human)0.017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1

Other Studies

1 other study(ies) available for arg-3-hyp-7-phe-bradykinin and phosphoramidon

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008